Masahiro Nozawa

1.8k total citations
117 papers, 1.1k citations indexed

About

Masahiro Nozawa is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Masahiro Nozawa has authored 117 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Pulmonary and Respiratory Medicine, 32 papers in Oncology and 24 papers in Cancer Research. Recurrent topics in Masahiro Nozawa's work include Prostate Cancer Treatment and Research (38 papers), Renal cell carcinoma treatment (23 papers) and Radiopharmaceutical Chemistry and Applications (16 papers). Masahiro Nozawa is often cited by papers focused on Prostate Cancer Treatment and Research (38 papers), Renal cell carcinoma treatment (23 papers) and Radiopharmaceutical Chemistry and Applications (16 papers). Masahiro Nozawa collaborates with scholars based in Japan, United States and United Kingdom. Masahiro Nozawa's co-authors include Hirotsugu Uemura, Kazuhiro Yoshimura, Takafumi Minami, Nobutaka Shimizu, Lothar Hennighausen, Norio Nonomura, Yutaka Yamamoto, Keiko Miyoshi, Robert D. Cardiff and Gertraud W. Robinson and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Masahiro Nozawa

108 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masahiro Nozawa Japan 17 478 395 329 146 128 117 1.1k
Lorna Marson United Kingdom 21 262 0.5× 537 1.4× 336 1.0× 204 1.4× 438 3.4× 48 1.5k
R. Guijarro Spain 18 635 1.3× 231 0.6× 389 1.2× 207 1.4× 180 1.4× 80 1.2k
Yongpeng Xie China 18 484 1.0× 397 1.0× 223 0.7× 246 1.7× 299 2.3× 87 1.0k
Harvey L. Bumpers United States 20 217 0.5× 191 0.5× 489 1.5× 272 1.9× 272 2.1× 69 1.2k
Francesco Puma Italy 23 866 1.8× 305 0.8× 415 1.3× 147 1.0× 590 4.6× 123 1.7k
Yoshiki Demura Japan 24 856 1.8× 202 0.5× 314 1.0× 123 0.8× 194 1.5× 83 1.5k
L. Riera Spain 20 291 0.6× 478 1.2× 128 0.4× 262 1.8× 487 3.8× 61 1.6k
Derek Pearson United Kingdom 22 187 0.4× 320 0.8× 439 1.3× 205 1.4× 201 1.6× 50 1.3k
Takashi Nishisaka Japan 18 586 1.2× 239 0.6× 246 0.7× 135 0.9× 473 3.7× 80 1.4k
Toby Silverman United States 14 320 0.7× 242 0.6× 214 0.7× 36 0.2× 239 1.9× 21 1.2k

Countries citing papers authored by Masahiro Nozawa

Since Specialization
Citations

This map shows the geographic impact of Masahiro Nozawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masahiro Nozawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masahiro Nozawa more than expected).

Fields of papers citing papers by Masahiro Nozawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masahiro Nozawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masahiro Nozawa. The network helps show where Masahiro Nozawa may publish in the future.

Co-authorship network of co-authors of Masahiro Nozawa

This figure shows the co-authorship network connecting the top 25 collaborators of Masahiro Nozawa. A scholar is included among the top collaborators of Masahiro Nozawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masahiro Nozawa. Masahiro Nozawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sazuka, Tomokazu, Katsunori Tatsugami, Suguru Shirotake, et al.. (2025). Outcomes of Nivolumab‐Plus‐Ipilimumab in Metastatic Renal Cell Carcinoma: Second Interim Analysis of the J‐ ENCORE Study. International Journal of Urology. 33(1). e70281–e70281.
2.
Fujita, Kazutoshi, Mamoru Hashimoto, Takashi Kikuchi, et al.. (2024). Gleason Pattern 5 May Be a Prognostic Factor in Radium-223 Treatment. Cancer Diagnosis & Prognosis. 4(4). 441–446.
3.
Sakai, Kazuko, Eri Banno, Takafumi Minami, et al.. (2023). Abstract 2877: Profiling of myeloid-derived suppressor cells in Pten-deficient in prostate cancer progression. Cancer Research. 83(7_Supplement). 2877–2877.
4.
Hashimoto, Mamoru, Kazutoshi Fujita, Eisuke Tomiyama, et al.. (2022). Immunohistochemical Analysis of HER2, EGFR, and Nectin-4 Expression in Upper Urinary Tract Urothelial Carcinoma. Anticancer Research. 43(1). 167–174. 9 indexed citations
5.
Nozawa, Masahiro, Yohei Okada, Sachiko Morita, et al.. (2022). Clinical relevance of impaired consciousness in accidental hypothermia: a Japanese multicenter retrospective study. SHILAP Revista de lepidopterología. 9(1). e730–e730. 1 indexed citations
6.
Okada, Yohei, Tasuku Matsuyama, Sachiko Morita, et al.. (2021). Machine learning-based prediction models for accidental hypothermia patients. Journal of Intensive Care. 9(1). 6–6. 5 indexed citations
7.
8.
Tomita, Yoshihiko, Katsunori Tatsugami, Noboru Nakaigawa, et al.. (2020). Cabozantinib in advanced renal cell carcinoma: A phase II, open‐label, single‐arm study of Japanese patients. International Journal of Urology. 27(11). 952–959. 22 indexed citations
9.
Okada, Yohei, Tasuku Matsuyama, Sachiko Morita, et al.. (2019). The development and validation of a “5A” severity scale for predicting in-hospital mortality after accidental hypothermia from J-point registry data. Journal of Intensive Care. 7(1). 1–1. 12 indexed citations
10.
Fujimoto, Yoshihiro, Tasuku Matsuyama, Sachiko Morita, et al.. (2019). Indoor Versus Outdoor Occurrence in Mortality of Accidental Hypothermia in Japan: The J-Point Registry. Therapeutic Hypothermia and Temperature Management. 10(3). 159–164. 6 indexed citations
11.
Okada, Yohei, Tasuku Matsuyama, Sachiko Morita, et al.. (2019). Prognostic ability of the sequential organ failure assessment score in accidental hypothermia: a multi-institutional retrospective cohort study. Scandinavian Journal of Trauma Resuscitation and Emergency Medicine. 27(1). 103–103. 6 indexed citations
12.
Okada, Michiko, et al.. (2017). A case of successful resuscitation after helium gas inhalation. Journal of Clinical Toxicology. 30(3). 251–253. 2 indexed citations
13.
14.
15.
Minami, Takafumi, Takafumi Minami, Nobutaka Shimizu, et al.. (2015). New polycomb group protein enhancer of zeste homolog (EZH) 2-derived peptide with the potential to induce cancer-reactive cytotoxic T lymphocytes in prostate cancer patients with HLA-A3 supertype alleles. International Immunopharmacology. 26(1). 133–138. 3 indexed citations
16.
Nozawa, Masahiro, Isao Hara, Hideyasu Matsuyama, et al.. (2014). Significance of baseline bone markers on disease progression and survival in hormone-sensitive prostate cancer with bone metastasis. World Journal of Urology. 33(9). 1263–1268. 6 indexed citations
17.
Inamoto, Teruo, Haruhito Azuma, Norio Nonomura, et al.. (2014). Favorable Outcome in Elderly Asian Patients with Metastatic Renal Cell Carcinoma Treated with Everolimus: The Osaka Urologic Oncology Group. Asian Pacific Journal of Cancer Prevention. 15(4). 1811–1815. 8 indexed citations
18.
Nishimura, Kazuo, Norio Nonomura, Yohei Ono, et al.. (2000). Oral Combination of Cyclophosphamide, Uracil plus Tegafur and Estramustine for Hormone-Refractory Prostate Cancer. Oncology. 60(1). 49–54. 28 indexed citations
19.
Nonomura, Norio, Tetsuo Imazu, Masahiro Nozawa, et al.. (1999). [Molecular staging of testicular cancer using polymerase chain reaction of the testicular cancer-specific genes].. PubMed. 45(8). 593–7. 7 indexed citations
20.
Nishimura, Kenji, et al.. (1995). Xanthoma of the Bladder. The Journal of Urology. 153(6). 1912–1913. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lorna Marson Breakdown of academic impact, for papers by R. Guijarro Breakdown of academic impact, for papers by Yongpeng Xie Breakdown of academic impact, for papers by Harvey L. Bumpers Breakdown of academic impact, for papers by Francesco Puma Breakdown of academic impact, for papers by Yoshiki Demura Breakdown of academic impact, for papers by L. Riera Breakdown of academic impact, for papers by Derek Pearson Breakdown of academic impact, for papers by Takashi Nishisaka Breakdown of academic impact, for papers by Toby Silverman
Rankless by CCL
2026